Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management

Impacting HCC Outcomes with Multimodal Therapy: The Importance of Interdisciplinary Management

imedex

1 month
5 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME: https://www.naccme.com/program/19-cio-201 This webcast features presentations that discuss best practices for improving outcomes in patients with hepatocelullar carcinoma (HCC) through interdisciplinary management. © 2019 NACCME, an HMP Company
Up Next Autoplay
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity
Category: Lymphoma
1,011 Views
imedex 5 months
Update: Relapsed/Refractory Follicular Lymphoma
Update: Relapsed/Refractory Follicular Lymphoma
Category: Lymphoma
390 Views
imedex 5 months
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Follicular Lymphoma: Update on Upfront and Maintenance Therapy
Category: Lymphoma
328 Views
imedex 5 months
CAR-T in Lymphoma
CAR-T in Lymphoma
Category: Lymphoma
244 Views
imedex 5 months
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Peripheral T-Cell Lymphoma: What is New on the Horizon?
Category: Lymphoma
227 Views
imedex 5 months
AML Case: A 54-year-old woman is in remission but MRD+
AML Case: A 54-year-old woman is in remission but MRD+
Category: Acute Myelogenous Leukemia
115 Views
imedex 6 months
Update: New Drugs for AML
Update: New Drugs for AML
Category: Acute Myelogenous Leukemia
177 Views
imedex 6 months
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
Category: Chronic Lymphocytic Leukemia
163 Views
imedex 6 months
CLL: Sequencing Monotherapy vs. Combination Therapy
CLL: Sequencing Monotherapy vs. Combination Therapy
Category: Chronic Lymphocytic Leukemia
88 Views
imedex 6 months